<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Glaucoma - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    

    
    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Glaucoma</span>
        </nav>

        <header class="page-header">
            <h1>Glaucoma</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Complex</span>
                
                
                <span class="badge badge-mondo">
                    <a href="https://monarchinitiative.org/disease/MONDO:0005041" target="_blank">
                        MONDO:0005041
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Ophthalmological Disease</span>
                
            </div>
        </header>

        <!-- Stats bar -->
        <div class="stats-bar">
            <div class="stat-item">
                <div class="stat-value">4</div>
                <div class="stat-label">Mechanisms</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">5</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">4</div>
                <div class="stat-label">Genes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">8</div>
                <div class="stat-label">Treatments</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">4</div>
                <div class="stat-label">Subtypes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Differentials</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
        </div>

        <!-- Subtypes -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #eef2ff; color: #4f46e5;">‚óÜ</div>
                <h2 class="card-title">Subtypes</h2>
                <span class="card-count">4</span>
            </div>
            
            <div class="item-box subtype-box">
                <div class="item-name">Primary Open-Angle Glaucoma</div>
                
                <div class="item-desc">Most common form, gradual onset with open drainage angle.</div>
                
                
    
    
            </div>
            
            <div class="item-box subtype-box">
                <div class="item-name">Angle-Closure Glaucoma</div>
                
                <div class="item-desc">Blocked drainage angle, can be acute or chronic.</div>
                
                
    
    
            </div>
            
            <div class="item-box subtype-box">
                <div class="item-name">Normal-Tension Glaucoma</div>
                
                <div class="item-desc">Optic nerve damage despite normal IOP.</div>
                
                
    
    
            </div>
            
            <div class="item-box subtype-box">
                <div class="item-name">Secondary Glaucoma</div>
                
                <div class="item-desc">Due to other conditions (trauma, steroids, uveitis).</div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Pathophysiology -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">‚öô</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">4</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Elevated Intraocular Pressure</div>
                
                <div class="item-desc">Impaired aqueous humor drainage through trabecular meshwork leads to increased IOP in most cases. Elevated pressure damages retinal ganglion cells and optic nerve.
</div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">Fluid Homeostasis</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/26497784" target="_blank">PMID:26497784</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Elevated intraocular pressure and aging, the main risk factors for glaucoma, accelerate RGC apoptosis."</div>
                
                
                <div class="evidence-explanation">Identifies elevated IOP as a main risk factor that accelerates retinal ganglion cell apoptosis in glaucoma.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Retinal Ganglion Cell Death</div>
                
                <div class="item-desc">Progressive apoptosis of retinal ganglion cells leads to irreversible vision loss. Mechanical stress, ischemia, and excitotoxicity contribute to cell death.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Retinal Ganglion Cell
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000740" target="_blank" style="color: inherit; margin-left: 4px;">‚Üó</a>
                        
                    </span>
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">Apoptosis</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/26497784" target="_blank">PMID:26497784</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Apoptosis of retinal ganglion cells (RGCs) in glaucoma causes progressive visual field loss, making it the primary cause of irreversible blindness worldwide."</div>
                
                
                <div class="evidence-explanation">Establishes that RGC apoptosis is the direct cause of visual field loss in glaucoma, confirming the central role of programmed cell death in disease pathogenesis.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/26302410" target="_blank">PMID:26302410</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"A glaucoma-associated mutant of optineurin, E50K, impairs autophagy as well as vesicle trafficking, leading to death of retinal cells by apoptosis."</div>
                
                
                <div class="evidence-explanation">Links OPTN mutations to RGC apoptosis through impaired autophagy, providing a molecular mechanism for how genetic variants cause retinal ganglion cell death.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/37542647" target="_blank">PMID:37542647</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Glaucoma is a leading cause of permanent blindness worldwide and is characterized by neurodegeneration linked to progressive retinal ganglion cell (RGC) death, axonal damage, and neuroinflammation."</div>
                
                
                <div class="evidence-explanation">Confirms that RGC death is a hallmark of glaucoma neurodegeneration and highlights the role of neuroinflammation in the degenerative process.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Optic Nerve Degeneration</div>
                
                <div class="item-desc">Loss of ganglion cell axons causes characteristic optic disc cupping. Progressive nerve fiber layer loss detectable before symptomatic visual field loss.
</div>
                
                
                
                
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Trabecular Meshwork Dysfunction</div>
                
                <div class="item-desc">Age-related changes, oxidative stress, and altered extracellular matrix reduce outflow facility. Increased resistance to aqueous outflow.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Trabecular Meshwork Cell
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0002367" target="_blank" style="color: inherit; margin-left: 4px;">‚Üó</a>
                        
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/10617907" target="_blank">PMID:10617907</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Myocilin gene is expressed clearly in the trabecular meshwork cells of both glaucomatous and nonglaucomatous eyes."</div>
                
                
                <div class="evidence-explanation">Confirms myocilin expression in trabecular meshwork cells, linking MYOC to the trabecular meshwork dysfunction in glaucoma.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/37217093" target="_blank">PMID:37217093</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The prevailing pathogenic mechanism involves a gain of toxic function whereby mutant myocilin aggregates intracellularly instead of being secreted, which causes cell stress and an early timeline for TM cell death, elevated intraocular pressure, and subsequent glaucoma-associated retinal degeneration."</div>
                
                
                <div class="evidence-explanation">Describes how mutant myocilin causes trabecular meshwork cell death through intracellular aggregation, directly linking MYOC mutations to trabecular dysfunction and elevated IOP.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Causal Graph -->
        

        <!-- Phenotypes -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">‚óè</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">5</span>
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Visual Field Loss
                    
                    <span class="phenotype-freq">VERY_FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Ophthalmological</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0001123" target="_blank">
                            HP:0001123
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Peripheral vision first</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/26497784" target="_blank">PMID:26497784</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Apoptosis of retinal ganglion cells (RGCs) in glaucoma causes progressive visual field loss, making it the primary cause of irreversible blindness worldwide."</div>
                
                
                <div class="evidence-explanation">Directly links RGC apoptosis to progressive visual field loss, the cardinal clinical manifestation of glaucoma.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Optic Disc Cupping
                    
                    <span class="phenotype-freq">VERY_FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Ophthalmological</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0000648" target="_blank">
                            HP:0000648
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Elevated Intraocular Pressure
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Ophthalmological</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0012632" target="_blank">
                            HP:0012632
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Not present in normal-tension glaucoma</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/37217093" target="_blank">PMID:37217093</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The prevailing pathogenic mechanism involves a gain of toxic function whereby mutant myocilin aggregates intracellularly instead of being secreted, which causes cell stress and an early timeline for TM cell death, elevated intraocular pressure, and subsequent glaucoma-associated retinal degeneration."</div>
                
                
                <div class="evidence-explanation">Links mutant MYOC to elevated IOP through trabecular meshwork cell death, establishing the mechanistic connection between genetic mutations and the elevated pressure phenotype.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Halos Around Lights
                    
                    <span class="phenotype-freq">OCCASIONAL</span>
                    
                    
                    <span class="phenotype-category">Ophthalmological</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0000505" target="_blank">
                            HP:0000505
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">More common in angle-closure</div>
                
                
                
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Eye Pain
                    
                    <span class="phenotype-freq">OCCASIONAL</span>
                    
                    
                    <span class="phenotype-category">Ophthalmological</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0200026" target="_blank">
                            HP:0200026
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Acute angle-closure glaucoma</div>
                
                
                
    
    
            </div>
            
        </div>
        

        <!-- Genetic Associations -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #dbeafe; color: #2563eb;">üß¨</div>
                <h2 class="card-title">Genetic Associations</h2>
                <span class="card-count">4</span>
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    MYOC
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Causative)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/37217093" target="_blank">PMID:37217093</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Mutations in the gene MYOC account for approximately 5% of cases of primary open angle glaucoma (POAG)."</div>
                
                
                <div class="evidence-explanation">Establishes MYOC as a causative gene for POAG, accounting for a significant proportion of cases.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/37217093" target="_blank">PMID:37217093</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"While myocilin is expressed in numerous tissues, mutant myocilin is only associated with disease in the anterior segment of the eye, in the trabecular meshwork."</div>
                
                
                <div class="evidence-explanation">Demonstrates tissue-specific pathogenicity of MYOC mutations in the trabecular meshwork of the eye.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    OPTN
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Risk Factor)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/26302410" target="_blank">PMID:26302410</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Certain mutations in optineurin (gene OPTN) are associated with primary open angle glaucoma."</div>
                
                
                <div class="evidence-explanation">Confirms OPTN mutations as a genetic risk factor for primary open angle glaucoma.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/26302410" target="_blank">PMID:26302410</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Thus, an optimum level of optineurin-mediated autophagy is crucial for survival of retinal cells, and impaired autophagy is likely to contribute to glaucoma pathogenesis."</div>
                
                
                <div class="evidence-explanation">Explains how OPTN variants contribute to glaucoma through dysregulated autophagy in retinal cells.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    WDR36
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Risk Factor)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    CAV1/CAV2
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Risk Factor)</span>
                    
                </div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Treatments -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">üíä</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">8</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Prostaglandin Analogs
                    
                </div>
                
                <div class="item-desc">First-line drops, increase uveoscleral outflow (latanoprost).</div>
                
                
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Beta-Blockers
                    
                </div>
                
                <div class="item-desc">Reduce aqueous production (timolol).</div>
                
                
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Alpha Agonists
                    
                </div>
                
                <div class="item-desc">Reduce production, increase outflow (brimonidine).</div>
                
                
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Carbonic Anhydrase Inhibitors
                    
                </div>
                
                <div class="item-desc">Reduce aqueous production (dorzolamide, brinzolamide).</div>
                
                
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Rho Kinase Inhibitors
                    
                </div>
                
                <div class="item-desc">Increase trabecular outflow (netarsudil).</div>
                
                
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Laser Trabeculoplasty
                    
                </div>
                
                <div class="item-desc">SLT increases trabecular outflow.</div>
                
                
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Trabeculectomy
                    
                </div>
                
                <div class="item-desc">Surgical filtration procedure.</div>
                
                
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    MIGS
                    
                </div>
                
                <div class="item-desc">Minimally invasive glaucoma surgery options.</div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ccfbf1; color: #0d9488;">üåç</div>
                <h2 class="card-title">Environmental Factors</h2>
                <span class="card-count">5</span>
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Age</div>
                
                <div class="item-desc">Major risk factor, increases after 40</div>
                
                
                
    
    
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Family History</div>
                
                <div class="item-desc">First-degree relatives at 4-9x increased risk</div>
                
                
                
    
    
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">African Ancestry</div>
                
                <div class="item-desc">Higher prevalence and severity</div>
                
                
                
    
    
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Myopia</div>
                
                <div class="item-desc">Risk factor for open-angle glaucoma</div>
                
                
                
    
    
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Corticosteroid Use</div>
                
                <div class="item-desc">Can induce steroid glaucoma</div>
                
                
                
    
    
            </div>
            
        </div>
        

        <!-- Biochemical Markers -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">üî¨</div>
                <h2 class="card-title">Biochemical Markers</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Intraocular Pressure
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Elevated)</span>
                    
                </div>
                
                <div class="item-desc">Context: Greater than 21 mmHg in most cases</div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Differential Diagnoses -->
        

        <!-- Datasets -->
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Glaucoma
category: Complex
parents:
- Ophthalmological Disease
disease_term:
  preferred_term: glaucoma
  term:
    id: MONDO:0005041
    label: glaucoma
has_subtypes:
- name: Primary Open-Angle Glaucoma
  description: Most common form, gradual onset with open drainage angle.
- name: Angle-Closure Glaucoma
  description: Blocked drainage angle, can be acute or chronic.
- name: Normal-Tension Glaucoma
  description: Optic nerve damage despite normal IOP.
- name: Secondary Glaucoma
  description: Due to other conditions (trauma, steroids, uveitis).
pathophysiology:
- name: Elevated Intraocular Pressure
  description: &gt;
    Impaired aqueous humor drainage through trabecular meshwork
    leads to increased IOP in most cases. Elevated pressure damages
    retinal ganglion cells and optic nerve.
  biological_processes:
  - preferred_term: Fluid Homeostasis
    term:
      id: GO:0030104
      label: water homeostasis
  evidence:
  - reference: PMID:26497784
    supports: SUPPORT
    snippet: &#34;Elevated intraocular pressure and aging, the main risk factors for glaucoma, accelerate RGC apoptosis.&#34;
    explanation: Identifies elevated IOP as a main risk factor that accelerates retinal ganglion cell apoptosis in glaucoma.
- name: Retinal Ganglion Cell Death
  description: &gt;
    Progressive apoptosis of retinal ganglion cells leads to
    irreversible vision loss. Mechanical stress, ischemia, and
    excitotoxicity contribute to cell death.
  cell_types:
  - preferred_term: Retinal Ganglion Cell
    term:
      id: CL:0000740
      label: retinal ganglion cell
  biological_processes:
  - preferred_term: Apoptosis
    term:
      id: GO:0006915
      label: apoptotic process
  evidence:
  - reference: PMID:26497784
    supports: SUPPORT
    snippet: &#34;Apoptosis of retinal ganglion cells (RGCs) in glaucoma causes progressive visual field loss, making it the primary cause of irreversible blindness worldwide.&#34;
    explanation: Establishes that RGC apoptosis is the direct cause of visual field loss in glaucoma, confirming the central role of programmed cell death in disease pathogenesis.
  - reference: PMID:26302410
    supports: SUPPORT
    snippet: &#34;A glaucoma-associated mutant of optineurin, E50K, impairs autophagy as well as vesicle trafficking, leading to death of retinal cells by apoptosis.&#34;
    explanation: Links OPTN mutations to RGC apoptosis through impaired autophagy, providing a molecular mechanism for how genetic variants cause retinal ganglion cell death.
  - reference: PMID:37542647
    supports: SUPPORT
    snippet: &#34;Glaucoma is a leading cause of permanent blindness worldwide and is characterized by neurodegeneration linked to progressive retinal ganglion cell (RGC) death, axonal damage, and neuroinflammation.&#34;
    explanation: Confirms that RGC death is a hallmark of glaucoma neurodegeneration and highlights the role of neuroinflammation in the degenerative process.
- name: Optic Nerve Degeneration
  description: &gt;
    Loss of ganglion cell axons causes characteristic optic disc
    cupping. Progressive nerve fiber layer loss detectable before
    symptomatic visual field loss.
- name: Trabecular Meshwork Dysfunction
  description: &gt;
    Age-related changes, oxidative stress, and altered extracellular
    matrix reduce outflow facility. Increased resistance to aqueous
    outflow.
  cell_types:
  - preferred_term: Trabecular Meshwork Cell
    term:
      id: CL:0002367
      label: trabecular meshwork cell
  evidence:
  - reference: PMID:10617907
    supports: SUPPORT
    snippet: &#34;Myocilin gene is expressed clearly in the trabecular meshwork cells of both glaucomatous and nonglaucomatous eyes.&#34;
    explanation: Confirms myocilin expression in trabecular meshwork cells, linking MYOC to the trabecular meshwork dysfunction in glaucoma.
  - reference: PMID:37217093
    supports: SUPPORT
    snippet: &#34;The prevailing pathogenic mechanism involves a gain of toxic function whereby mutant myocilin aggregates intracellularly instead of being secreted, which causes cell stress and an early timeline for TM cell death, elevated intraocular pressure, and subsequent glaucoma-associated retinal degeneration.&#34;
    explanation: Describes how mutant myocilin causes trabecular meshwork cell death through intracellular aggregation, directly linking MYOC mutations to trabecular dysfunction and elevated IOP.
phenotypes:
- name: Visual Field Loss
  category: Ophthalmological
  frequency: VERY_FREQUENT
  diagnostic: true
  notes: Peripheral vision first
  phenotype_term:
    preferred_term: Visual Field Defect
    term:
      id: HP:0001123
      label: Visual field defect
  evidence:
  - reference: PMID:26497784
    supports: SUPPORT
    snippet: &#34;Apoptosis of retinal ganglion cells (RGCs) in glaucoma causes progressive visual field loss, making it the primary cause of irreversible blindness worldwide.&#34;
    explanation: Directly links RGC apoptosis to progressive visual field loss, the cardinal clinical manifestation of glaucoma.
- name: Optic Disc Cupping
  category: Ophthalmological
  frequency: VERY_FREQUENT
  diagnostic: true
  phenotype_term:
    preferred_term: Optic Atrophy
    term:
      id: HP:0000648
      label: Optic atrophy
- name: Elevated Intraocular Pressure
  category: Ophthalmological
  frequency: FREQUENT
  notes: Not present in normal-tension glaucoma
  phenotype_term:
    preferred_term: Elevated IOP
    term:
      id: HP:0012632
      label: Abnormal intraocular pressure
  evidence:
  - reference: PMID:37217093
    supports: SUPPORT
    snippet: &#34;The prevailing pathogenic mechanism involves a gain of toxic function whereby mutant myocilin aggregates intracellularly instead of being secreted, which causes cell stress and an early timeline for TM cell death, elevated intraocular pressure, and subsequent glaucoma-associated retinal degeneration.&#34;
    explanation: Links mutant MYOC to elevated IOP through trabecular meshwork cell death, establishing the mechanistic connection between genetic mutations and the elevated pressure phenotype.
- name: Halos Around Lights
  category: Ophthalmological
  frequency: OCCASIONAL
  notes: More common in angle-closure
  phenotype_term:
    preferred_term: Visual Impairment
    term:
      id: HP:0000505
      label: Visual impairment
- name: Eye Pain
  category: Ophthalmological
  frequency: OCCASIONAL
  notes: Acute angle-closure glaucoma
  phenotype_term:
    preferred_term: Eye Pain
    term:
      id: HP:0200026
      label: Ocular pain
biochemical:
- name: Intraocular Pressure
  presence: Elevated
  context: &#34;Greater than 21 mmHg in most cases&#34;
genetic:
- name: MYOC
  association: Causative
  notes: Primary open-angle glaucoma
  evidence:
  - reference: PMID:37217093
    supports: SUPPORT
    snippet: &#34;Mutations in the gene MYOC account for approximately 5% of cases of primary open angle glaucoma (POAG).&#34;
    explanation: Establishes MYOC as a causative gene for POAG, accounting for a significant proportion of cases.
  - reference: PMID:37217093
    supports: SUPPORT
    snippet: &#34;While myocilin is expressed in numerous tissues, mutant myocilin is only associated with disease in the anterior segment of the eye, in the trabecular meshwork.&#34;
    explanation: Demonstrates tissue-specific pathogenicity of MYOC mutations in the trabecular meshwork of the eye.
- name: OPTN
  association: Risk Factor
  notes: Normal-tension glaucoma
  evidence:
  - reference: PMID:26302410
    supports: SUPPORT
    snippet: &#34;Certain mutations in optineurin (gene OPTN) are associated with primary open angle glaucoma.&#34;
    explanation: Confirms OPTN mutations as a genetic risk factor for primary open angle glaucoma.
  - reference: PMID:26302410
    supports: SUPPORT
    snippet: &#34;Thus, an optimum level of optineurin-mediated autophagy is crucial for survival of retinal cells, and impaired autophagy is likely to contribute to glaucoma pathogenesis.&#34;
    explanation: Explains how OPTN variants contribute to glaucoma through dysregulated autophagy in retinal cells.
- name: WDR36
  association: Risk Factor
- name: CAV1/CAV2
  association: Risk Factor
environmental:
- name: Age
  notes: Major risk factor, increases after 40
- name: Family History
  notes: First-degree relatives at 4-9x increased risk
- name: African Ancestry
  notes: Higher prevalence and severity
- name: Myopia
  notes: Risk factor for open-angle glaucoma
- name: Corticosteroid Use
  notes: Can induce steroid glaucoma
treatments:
- name: Prostaglandin Analogs
  description: First-line drops, increase uveoscleral outflow (latanoprost).
- name: Beta-Blockers
  description: Reduce aqueous production (timolol).
- name: Alpha Agonists
  description: Reduce production, increase outflow (brimonidine).
- name: Carbonic Anhydrase Inhibitors
  description: Reduce aqueous production (dorzolamide, brinzolamide).
- name: Rho Kinase Inhibitors
  description: Increase trabecular outflow (netarsudil).
- name: Laser Trabeculoplasty
  description: SLT increases trabecular outflow.
- name: Trabeculectomy
  description: Surgical filtration procedure.
- name: MIGS
  description: Minimally invasive glaucoma surgery options.
datasets:
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Glaucoma.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
</body>
</html>